Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Who bears the burden of Medicaid drug copayment policies?

Stuart B, Zacker C.

Health Aff (Millwood). 1999 Mar-Apr;18(2):201-12.

PMID:
10091449
2.

Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population.

Hartung DM, Carlson MJ, Kraemer DF, Haxby DG, Ketchum KL, Greenlick MR.

Med Care. 2008 Jun;46(6):565-72. doi: 10.1097/MLR.0b013e3181734a77.

PMID:
18520310
3.

Medicaid policies for HIV-related prescription drugs.

Buchanan RJ, Smith SR.

Health Care Financ Rev. 1994 Spring;15(3):43-61.

4.

Chronic Health Outcomes and Prescription Drug Copayments in Medicaid.

Kostova D, Fox J.

Med Care. 2017 May;55(5):520-527. doi: 10.1097/MLR.0000000000000700.

PMID:
28234755
5.
6.
7.

The effect of a Medicaid drug copayment program on the utilization and cost of prescription services.

Nelson AA Jr, Reeder CE, Dickson WM.

Med Care. 1984 Aug;22(8):724-36.

PMID:
6433121
8.

Increasing time costs and copayments for prescription drugs: an analysis of policy changes in a complex environment.

Domino ME, Martin BC, Wiley-Exley E, Richards S, Henson A, Carey TS, Sleath B.

Health Serv Res. 2011 Jun;46(3):900-19. doi: 10.1111/j.1475-6773.2010.01237.x. Epub 2011 Feb 9.

9.

Modeling the potential impact of a prescription drug copayment increase on the adult asthmatic medicaid population.

Bae SJ, Paltiel AD, Fuhlbrigge AL, Weiss ST, Kuntz KM.

Value Health. 2008 Jan-Feb;11(1):110-8. doi: 10.1111/j.1524-4733.2007.00219.x.

10.

Managing Medicaid drug expenditures.

Sudovar SG Jr, Rein SD.

J Health Hum Resour Adm. 1978 Nov;1(2):200-30. No abstract available.

PMID:
10308767
11.
12.

Effect on drug utilization and expenditures of a cost-share change from copayment to coinsurance.

Klepser DG, Huether JR, Handke LJ, Williams CE.

J Manag Care Pharm. 2007 Nov-Dec;13(9):765-77.

13.

Prescription drugs: issues of cost, coverage, and quality.

Copeland C.

EBRI Issue Brief. 1999 Apr;(208):1-21.

PMID:
10539445
14.

Differences in the cost of antidepressants across state Medicaid programs.

Kelton CM, Rebelein RP, Heaton PC, Ferrand Y, Guo JJ.

J Ment Health Policy Econ. 2008 Mar;11(1):33-47.

PMID:
18424875
15.

Prescription drug access: not just a Medicare problem.

Cunningham PJ.

Issue Brief Cent Stud Health Syst Change. 2002 Apr;(51):1-4.

PMID:
11977267
16.

Insurance coverage for prescription drugs: effects on use and expenditures in the Medicare population.

Lillard LA, Rogowski J, Kington R.

Med Care. 1999 Sep;37(9):926-36.

PMID:
10493470
17.

The effect of emergency department copayments for Medicaid beneficiaries following the Deficit Reduction Act of 2005.

Siddiqui M, Roberts ET, Pollack CE.

JAMA Intern Med. 2015 Mar;175(3):393-8. doi: 10.1001/jamainternmed.2014.7582.

18.

Trends in prescription drug expenditures by Medicaid enrollees.

Banthin JS, Miller GE.

Med Care. 2006 May;44(5 Suppl):I27-35.

PMID:
16625061
19.

Can increases in CHIP copayments reduce program expenditures on prescription drugs?

Sen B, Blackburn J, Morrisey M, Becker D, Kilgore M, Caldwell C, Menachemi N.

Medicare Medicaid Res Rev. 2014 May 20;4(2). pii: mmrr2014.004.02.a03. doi: 10.5600/mmrr2014-004-02-a03. eCollection 2014.

20.

Racial and ethnic disparities in the financial burden of prescription drugs among older Americans.

Xu KT, Borders TF.

J Health Hum Serv Adm. 2007 Summer;30(1):28-49.

PMID:
17557695

Supplemental Content

Support Center